September 2026
The genetic editing for ASCVD market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2026
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
September 2026
The next-gen delivery systems for genetic drug market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The molecular cytogenetics market size reached USD 3.20 billion in 2026, with leading molecular cytogenetics market companies including Thermo Fisher Scientific, Illumina, Danaher, Roche Diagnostics.
September 2026
The global gene editing market size was valued at USD 12.46 billion in 2026 and is expected to hit around USD 45.06 billion by 2035, growing at a CAGR of 15.39% from 2026 and 2035.
September 2026
The global genetic testing market size is calculated at USD 27.32 billion in 2026 and is projected to hit around USD 71.09 billion by 2035 with a soild CAGR of 11.26%.
September 2026
The global genome editing market size is evaluated at USD 12.76 billion in 2026 and is projected to worth around USD 48.19 billion by 2035 with a CAGR of 16.01%.
September 2026
The global animal genetics market size was estimated at USD 7.36 billion in 2026 and is expected to hit around USD 12.67 billion by 2035, growing at a CAGR of 6.23%.
September 2026
The genetically modified feed market size was valued at USD 112.17 billion in 2026 and is expected to hit around USD 171.76 billion by 2034, growing at a CAGR of 5.48%.
September 2026
The epigenetics diagnostics market size was evaluated at USD 22.40 billion in 2026 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global RNA editing market size was valued at USD 16.91 billion in 2026 and is expected to surpass around USD 27.79 billion by 2035, growing at a CAGR of 5.71% from 2026 to 2035.
September 2026
The global genetic toxicology testing market size was evaluated at USD 2.49 billion in 2026 and is predicted to hit around USD 5.97 billion by 2035, growing at a CAGR of 10.20%.
September 2026
The optogenetics market size reached USD 784.04 million in 2026, with leading optogenetics market companies including Thorlabs, Inc., Coherent Corp., Scientifica Ltd., Bruker Corporation, PerkinElmer, Inc.
September 2026
The global genetic analysis market size was valued at USD 9.05 billion in 2026 and is expected to attain around USD 21.67 billion by 2034 with a CAGR of 11.08%.
September 2026
The genetic engineering in agriculture market reached USD 1.34 billion in 2026, featuring leading genetic engineering in agriculture market companies such as Corteva Agriscience, Bayer AG, Syngenta AG.
August 2026
The predictive genetic counselling market size stood at USD 3.54 billion in 2026, with major predictive genetic counselling market companies including Invitae Corporation, Myriad Genetics, Quest Diagnostics, Natera Inc. .
August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
July 2026
The global CRISPR-based gene editing market size is accounted to hit around USD 14.96 billion by 2035 increasing from USD 4.95 billion in 2026, with a CAGR of 12.87%.
July 2026
The phase Ib gene editing trials market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global genetic engineering market size was estimated at USD 1.83 billion in 2026 and is expected to hit around USD 3.10 billion by 2035, growing at a CAGR of 6.07% from 2026 to 2035.
June 2026
The global prenatal and newborn genetic testing market size is projected to hit around USD 30.94 billion by 2035, increasing from USD 10.48 billion in 2026, with at a solid CAGR of 12.8%.
September 2026
The bioengineering market was valued at USD 347.04 billion in 2026, with leading companies including Roche Holding AG, Agilent Technologies, Johnson & Johnson.
September 2026
The global infant formula market size is calculated at USD 99.07 billion in 2026 and is projected to surpass USD 221.06 billion by 2035 with a CAGR of 9.35%.
September 2026
The global thermal management for 5G market size was valued at USD 12.69 billion in 2026 and is expected to hit around USD 20.62 billion by 2035, growing at a CAGR of 5.55%.
September 2026
The global e-learning for pet services market size was valued at USD 2.14 billion in 2026 and is expected to hit around USD 7.52 billion by 2035, growing at a CAGR of 15.05%
September 2026
The global medical information market size reached USD 3.44 billion in 2026 and is projected to surpass around USD 6.04 billion by 2034 with a notable CAGR of 7.32%.
September 2026
The global digital transformation in BFSI market size is estimated to surpass around USD 468.65 billion by 2035 from USD 126.56 billion in 2026 with a solid CAGR of 15.75%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com